Abstract Patients with immune thrombocytopenia have increased risks of bleeding and thrombosis. The acute‐phase treatment for venous thromboembolism complicated with severe immune thrombocytopenia involves a “platelet dilemma” in therapeutic decision‐making
Venous thromboembolic disease is an important cause of mortality worldwide. A widely recognized risk...
Venous thromboembolic events (VTEs) in hospitalized patients with thrombocytopenia, especially the a...
The rarity of severe complications of this disease in children makes randomized clinical trials in i...
Abstract Background Immune thrombocytopenia is an acquired autoimmune disease. Recently, there has b...
Patients with active bleeding complications who concomitantly develop overt pulmonary embolism (PE) ...
The value of combination therapy for refractory ITP is not well defined. We present the case of a 29...
This case demonstrates the therapeutic challenges encountered when managing an acute pulmonary embol...
AbstractEssential thrombocythemia (ET), a chronic myeloproliferative disease, is characterized by an...
Venous thromboembolism that occurs in unusual sites is challenging because of the potential severity...
Immune thrombocytopenia with antiphospholipid syndrome and monoclonal gammopathy of undetermined sig...
Thrombocytopenia (TP) is a common finding in patients hospitalized for cardiovascular causes and nee...
Venous thromboembolism (VTE) is relatively common among patients with haematological malignancies. M...
Treatment of patients with immune thrombocytopenia (ITP) is often directed at increasing the platele...
Thrombotic thrombocytopenic purpura (TTP) describes syndromes with multiple etiologies, some of whic...
The novel coronavirus SARS-CoV-2 can cause a severe and even fatal respiratory illness named COVID-1...
Venous thromboembolic disease is an important cause of mortality worldwide. A widely recognized risk...
Venous thromboembolic events (VTEs) in hospitalized patients with thrombocytopenia, especially the a...
The rarity of severe complications of this disease in children makes randomized clinical trials in i...
Abstract Background Immune thrombocytopenia is an acquired autoimmune disease. Recently, there has b...
Patients with active bleeding complications who concomitantly develop overt pulmonary embolism (PE) ...
The value of combination therapy for refractory ITP is not well defined. We present the case of a 29...
This case demonstrates the therapeutic challenges encountered when managing an acute pulmonary embol...
AbstractEssential thrombocythemia (ET), a chronic myeloproliferative disease, is characterized by an...
Venous thromboembolism that occurs in unusual sites is challenging because of the potential severity...
Immune thrombocytopenia with antiphospholipid syndrome and monoclonal gammopathy of undetermined sig...
Thrombocytopenia (TP) is a common finding in patients hospitalized for cardiovascular causes and nee...
Venous thromboembolism (VTE) is relatively common among patients with haematological malignancies. M...
Treatment of patients with immune thrombocytopenia (ITP) is often directed at increasing the platele...
Thrombotic thrombocytopenic purpura (TTP) describes syndromes with multiple etiologies, some of whic...
The novel coronavirus SARS-CoV-2 can cause a severe and even fatal respiratory illness named COVID-1...
Venous thromboembolic disease is an important cause of mortality worldwide. A widely recognized risk...
Venous thromboembolic events (VTEs) in hospitalized patients with thrombocytopenia, especially the a...
The rarity of severe complications of this disease in children makes randomized clinical trials in i...